Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema

We present a patient with SDRIFE secondary to lenalidomide, an immunomodulatory agent. This case highlights the importance of considering SDRIFE in the differential diagnosis of patients presenting with intertriginous erythema.PMID:37921816 | DOI:10.5070/D329461905

Source: Dermatol Online J - November 3, 2023 Category: Dermatology Authors: Riya T Patel Eugenie Y Quan Joshua D Eikenberg Douglas J Grider Mariana A Phillips Source Type: research